SALT ALTERNATIVES
The average person gets far too much sodium because we eat too much salt (sodium chloride) and not enough potassium and magnesium. The net result is water retention and weight gain, anxiety, insomnia, high blood pressure, and muscle cramps. Not all salt, however, is bad for you. Solo Low Sodium Sea Salt contains 60 percent less sodium and is high in the essential minerals magnesium and potassium. To purchase Solo Sea Salt, contact Daily Vitality Health Products at 800-618-1810.
SKIN-CARE PRODUCTS
Environ products were developed by cosmetic surgeon Dr. Des Fernandes to prevent skin cancer and address the damaging effects of the environment on our skin. Formulated with scientifically proven active ingredients including Vitamin A and antioxidant vitamins C, E, and beta-carotene, which are used in progressively higher concentrations, Environ will maintain a normal healthy skin, especially when there are signs of aging, pigmentation, problem skin, and scarring. To purchase Environ products, contact Daily Vitality Health Products at 800-618-1810, or DermaCare USA at 877-337-6227.
COFFEE AND TEA ALTERNATIVES
Teeccino: Found in health food stores, through Teeccino Caffé, Inc., 800-498-3434, www.teeccino.com, or through Daily Vitality Health Products, 800-618-1810, www.holfordhealth.com
Red Rooibos herbal tea: Found in health food stores; or Daily Vitality Health Products, 800-618-1810, www.holfordhealth.com
Tests
GENERAL TESTS
Laboratory tests are available for all the tests mentioned in this book, through qualified nutrition consultants and doctors. Leading laboratories include:
York Nutritional Laboratories
888-751-3388
www.yorkallergyusa.com
York Nutritional Laboratories offer a wide range of tests and specialize in testing that utilizes finger-prick blood samples that can be carried out at home.
Immuno Laboratories
1620 W. Oaklands Pk Boulevard
Fort Lauderdale, FL 33311
Tel: (954) 486 4500
Fax: (954) 739 6563
www.immunolab.com
Aeron Life Cycles Laboratory
1933 Davis Street, Suite 310
San Leandro, CA 94577
Tel: (800) 631 7900
Fax: (510) 729 0383
www.aeron.com
Great Smokies
63 Zillicoa Street
Asheville, NC 28801-1074
Tel: (704) 253 0621
Fax: (704) 252 9303
www.gsdl.com
Diagnostech
6620501 92nd Place J-104
Kent, WA 98022
Tel: (425) 251 0596
Fax: (425) 251 0637
www.diagnostech.com
Supplement, remedy and supplier directory
Finding your own perfect supplement program can be confusing, but my website www.holfordhealth.com offers useful guidance.
The backbone of a good supplement program is:
A high-strength multivitamin
Additional vitamin C
An all-round antioxidant complex
An essential-fat supplement containing omega-3 and omega-6 oils
The following companies produce good-quality supplements that are widely available in the US:
Solgar Vitamin and Herb
Website has “where to buy” function for retail stores and online e-stores:
877-SOLGAR-4
www.solgar.com
Enzymatic Therapy, Inc.
Website has “where to buy” function for retail stores and online e-stores:
800-783-2286
www.enzy.com
Nature’s Plus
Website has store locator:
www.naturesplus.com
Source Naturals
Website has “where to buy” function for retail stores and online e-stores:
800-815-2333
www.sourcenaturals.com
Twinlab Corporation
Website only gives information on products:
800-645-5626
www.twinlab.com
And in other regions
United Kingdom: Health Products for Life offers a wide range of health products, which I recommend, from supplements to water filters, by mail and online. You can also order by phone at +44 (0)20 8874 8038, or visit their website at www.healthproductsforlife.com.
South Africa: Bioharmony produces a wide range of products in South Africa and other African countries. For details of your nearest supplier, call 0860 888 339 or visit www.bioharmonyco.za.
Australia: Solgar supplements are available in Australia. Contact Solgar at 1800 029 871 (toll-free) for your nearest supplier. Website: www.solgar.com.au. Another good brand is Blackmores.
New Zealand: Higher Nature products are available in New Zealand. Contact Aurora Natural Therapies, 4 La Trobe Track, KareKare, Waitakere City, Auckland 1232, or visit www.aurora.org.nz.
Singapore: HigherNature and Solgar products are available in Singapore. Contact Essential Living on 6276 1380 for your nearest supplier or visit www.essliv.com.
References
Part 1
1. Stephens, N., et al. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (9004): 781–86.
2. Braly, J., and P. Holford. 2003. The H Factor. London: Piatkus Books.
3. Bergkvist, L., et al. 1989. The risk of breast cancer after estrogen and estrogen-progestin replacement. New England Journal of Medicine 32: 293–97.
4. Rodriguez, C, et al. 1995. Estrogen replacement therapy and fatal ovarian cancer. American Journal of Epidemiology 141 (9): 828–35.
5. Million Women Study collaborators. 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419–27.
6. The aquatic ape. 1993. Nutrition and Health 9: 3.
7. Ibid.
8. Willatts, P., et al. 2003. Effects of long-chain polyunsaturated fatty acid supplementation in infancy on cognitive function in later childhood. Maternal and Infant LCPUFA Workshop. Meeting of the American Oil Chemists Society, Kansas City, April 2003.
9. Cheraskin, E. 1993. The breakfast/lunch/dinner ritual. Journal of Orthomolecular Medicine 8: 6–10.
10. Braly, J., and R. Hoggan. 2002. Dangerous Grains: Why Gluten Cereal Grains May Be Hazardous to Your Health. Avery Publishing Group, UK.
11. Popper, H., and F. J. Steigmann. 1943. Journal of the American Medical Association 123: 1108–14.
12. Hoffer, A., and H. Osmond. 1964. Treatment of schizophrenia with nicotinic acid. Acta Psychiatrica Scandinavia 40: 171–89; A. Hoffer. 1994. Chronic schizophrenic patients treated ten years or more. Journal of Orthomolecular Medicine 9 (1): 1–37.
13. Barker, H. MRC Environmental Epidemiology Unit, Southampton, UK.
14. Bryce-Smith, D. 1986. Pre-natal zinc deficiency. Nursing Times (March 5): 44–46.
15. Schoenthaler, S., et al. 1991. Controlled trial of vitamin-mineral supplementation on intelligence and brain function. Personality and Individual Differences 12 (4): 343–50; S. Schoenthaler, et al. 1991. Controlled trial of vitamin-mineral supplementation: Effects on intelligence and performance. Ibid: 351–62.
16. Gesch, B. 1990. The SCASO Project. International Journal of Biosocial Medical Research 12 (1): 41–68.
17. Koyama, K., et al. 2002. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folate supplementation. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association 17: 916–22.
18. Schectman, G., et al. 1991. Ascorbic acid requirements for smokers: Analysis of a population survey. American Journal of Clinical Nutrition 53 (June): 1466–70.
19. Ash, J. Investigation into the mechanisms of the effects of 220 dyes on hyperactive children. Final-year project, School of Biological Sciences, University of Surrey, Guildford, UK. Copy held by Dr. Neil Ward.
; 20. Heaton, S. A. A. 2001. Organic Farming, Food Quality and Human Health: A review of the evidence. Bristol, UK: Soil Association.
21. MAFF. 1999. Annual Report of the Working Party on Pesticide Residues 1998. London: Health and Safety Executive, MAFF Publications.
22. Abou-Donia, M. B., et al. 1996. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET and permethrin: Implications for Gulf War chemical exposures. Journal of Toxicology and Environmental Health 48: 35–65.
23. Nott, T. 1997. Washing aid for fruit and vegetables. Pesticides News 35; Pesticides in fruit and vegetables. 1998. Health Which? (June): 8–11.
24. Benbrook, C. M. 2003. Impacts of Genetically Engineered Crops on Pesticide Use in the United States: The First Eight Years. BioTech InfoNet, Technical Paper No. 6 (November).
Part 2
1. British Medical Association. 1999. The impact of genetic modification on agriculture. Food & Health Report. BMA.
2. Dickerson, J. W. T., et al. 1985. Disease patterns in individuals with different eating patterns. Journal of the Royal Society of Health 105: 191–94.
3. American Journal of Public Health. 1997.
4. Knight, E., et al. 2003. Annals of Internal Medicine 138 (March 18): 460–7.
5. Feskanich, D., et al. 1996. Protein consumption and bone fractures in women. American Journal of Epidemiology 143: 472–79.
6. Reddy, S., et al. 2002. Effect of low-carbohydrate, high-protein diets on acid-base balance, stone-forming propensity. American Journal of Kidney Diseases 40: 265–74.
7. Murata, K., et al. 2004. Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury. Journal of Pediatrics 144 (2): 177–83; P. Grandjean, et al. Cardia autonomic activity in methylmercury neurotoxicity: 14-year follow-up of Faroese birth cohort. Ibid: 169–76.
8. Anderson, et al. 1999. Breast-feeding and cognitive development: A meta-analysis. American Journal of Clinical Nutrition 70: 525–35.
9. Moss, M., and D. Freed. 2003. The cow and the coronary. International Journal of Cardiology 87: 203–16.
10. Malin, A., et al. 2004. Evaluation of the synergistic effect of insulin resistance and IGF on the risk of breast carcinoma. Cancer 100 (4): 694–700.
11. Oliver, S. E., et al. 2004. Screen-detected prostate cancer and IGE International Journal of Cancer 108 (6): 887–92.
12. The Immunology Review 2 (Spring 1994).
13. Granfeldt, Y., I. Byorck, and B. Hagander. 1991. On the importance of processing conditions, product thickness and egg addition for the glycaemic and hormonal responses to pasta: A comparison of bread made with “pasta ingredients.” European Journal of Clinical Nutrition 45: 489–99.
14. Richardson, N. J., P. J. Rogers, et al. 1995. Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacology, Biochemistry and Behavior 52 (2): 313–20.
15. Gilliland, K., and D. Andress. 1981. Ad lib caffeine consumption, symptoms of caffeinism, and academic performance. American Journal of Psychiatry 138 (4): 512–14.
16. See full references at www.doctoryourself.com/caffeine_allergy.html.
17. Davies, S. 1993. The myth of the balanced diet. Power of Prevention Conference. Available from the Institute of Optimum Nutrition (cassette T16, “The myth of the balanced diet”).
18. Bateman Catering Organisation. 1981. A square meal for Britain?
19. Seal, E. C, J. Metz, L. Flicker, and J. Melny. 2002. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. Journal of the American Geriatric Society 50 (1): 146–51.
20. The Vitamin Controversy. 1987. ION Press.
21. Cheraskin, E., et al. 1994. Establishing a suggested optimum nutrition allowance (SONA); What is optimum? 1994. Optimum Nutrition Magazine 7 (2): 46–47.
22. Milunsky, A., et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. Journal of the American Medical Association 262 (20): 2847–52.
23. Chandra, R. K. 2001. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 17 (9): 709–12.
24. Chandra, R. K. 1992. Study of multivitamin/mineral supplementation in elderly. Lancet 340: 1124–27.
25. Hemila, H., et al. 1995. Vitamin C and the common cold: A retrospective analysis of Chalmers’ review. Journal of the American College of Nutrition 14 (2): 116–23.
26. Stephens, N., et al. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (9004): 781–86.
27. Geleijnse, J., et al. 1994. Reduction of blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. British Medical Journal 309: 436–40.
28. Salonen, J. T., K. Nyyssonen, H. Korpela, et al. 1992. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86: 803–11.
29. Lodge Rees, E. 1979. Aluminium toxicity as indicted by hair analysis. Journal of Orthomolecular Psychiatry 8 (1): 37–43.
30. Cowdry, Quentin, and Stokes. 1989. Aluminium in the water causes senile dementia. Daily Telegraph (January 13).
31. Rifat, L., et al. 1990. Effect of exposure of miners to aluminium powder. Lancet 336: 1162–65.
32. Suay Llopis, L., and F. Ballester Diez. 2002. Review of studies on exposure to aluminium and Alzheimer’s disease. Revista Espana Salud Publica 76 (6): 645–58; A. Campbell. 2002. The potential role of aluminium in Alzheimer’s disease. Nephrology Dialysis Transplantation 17 (Suppl 2): 17–20.
33. Becaria, A., S. C. Bondy, and A. Campbell. 2003. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: Implications for Alzheimer’s disease. Journal of Alzheimer’s Disease 5 (1): 31–38.
34. Holford, P., and C. Pfeiffer. 1996. Mental Health and Mental Illness-The Nutrition Connection. London: ION Press. Also see www.mentalhealthproject/features for feature on copper and schizophrenia.
35. Needleman, H. L., and C. A. Gatsonis. 1990. Low-level lead exposure and the IQ of children. Journal of the American Medical Association 263 (5): 673–78.
36. Yule, Q., R. Lansdown, et al. 1981. The relationship between blood lead concentrations, intelligence and attainment in a school population: A pilot study. Developmental Medicine and Child Neurology 23 (5): 567–76.
37. Ward, N. I., and D. Bryce-Smith. 1995. Lead, cadmium and zinc levels in relation to fetal development and abnormalities. Heavy Metals in the Environment 2: 280–84.
38. Smith, L. H., with J. G. Hattersley. 2002. The Infant Survival Guide: Protecting Your Baby from the Dangers of Crib Death, Vaccines and Other Environmental Hazards. Petaluma, California: Smart Publications.
39. Mercola, J. 2002. What you must know before eating fish. www.mercola.com.
40. Schober, S. E., et al. 2003. Blood mercury levels in U.S. children and women of childbearing age, 1999–2000. Journal of the American Medical Association 289 (2003): 1667–74.
41. Wenstrup, D., et al. 1990. Trace element imbalances in isolated subcellular fractions of Alzheimer’s disease patients Brain Research 553: 125–31.
42. Hock, C., et al. 1998. Increased blood mercury levels in patients with Alzheimer’s disease. Journal of Neural Transmission 105 (1): 59–68.
43. Leong, C. C., et al. 2001. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 12 (4): 733–37. See also www.commons.ucalgary.ca/mercury.
44. Goyer, R., and M. G. Cherian. 1979. Ascorbic acid and EDTA treatment of lead toxicity in rats. Life Science 24 (5): 433–38.
45. O’Flaherty, E. J. 2000. Modeling normal aging bone loss, with consideration of bone loss in osteoporosis. Toxicological Sciences 55 (1): 171–88.
46. Aaman, Z., et a
l. 1992. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s Disease. Age and Aging 21 (March): 91–94.
47. Morris, M., et al. 1998. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Disease and Associated Disorders 12: 121–26.
48. Morris, M., et al. 2002. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. Journal of the American Medical Association 287 (24): 3230–37. Also see pp. 3223–61.
49. Jacques, P. F. 1992. Relationship of vitamin C status to cholesterol and blood pressure. Annals of the New York Academy of Sciences 669: 205–14.
50. Bond, G., et al. 1987. Dietary vitamin A and lung cancer: Results of a case control study among chemical workers. Nutrition and Cancer 9: 109–21. Robertson, J. M., et al. 1989. Vitamin E intake and risk of cataracts in humans. Annals of the New York Academy of Sciences 570: 372–82.
51. Mayne, S. T. 1994. Dietary beta carotene and lung cancer risk in US nonsmokers. Journal of the National Cancer Institute 86 (1): 33–38.
52. Garewal, H. S., et al. 1990. Response of oral leukophakia to beta-carotene. Journal of Clinical Oncology 8: 1715–20.
53. Manson, J. E., et al. 1991. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Abstract in Circulation 84 (4): 11–546.
54. Osilesi, O., et al. 1991. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutrition Research 11: 405–12.
55. Wald, D. S., and J. K. Morris. 2002. British Medical Journal 325: 1202.
56. Clerk, M., et al. 2002. MTHFR 677C→T polymorphism and risk of coronary heart disease. Journal of the American Medical Association 288 (16): 2023–31.
57. Lichtenstein, P., et al. 2000. Environmental and heritable factors in the causation of cancer. New England Journal of Medicine 343 (2): 135–36.
58. Toshifumi, M., et al. 2001. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 32: 1116.
The New Optimum Nutrition Bible Page 53
